2017

1. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

   Journal of the American Academy of Dermatology, Vol. 76, Núm. 1, pp. 60-69.e9